About this event
Following the release of the Phase 1/2 results for AEF0217 in Down syndrome, Aelis Farma is pleased to invite you to an interactive webinar on Tuesday, November 19, 2024, at 4:00 pm (CET) / 10:00 am (ET).
Pier Vincenzo Piazza, CEO and Stéphanie Monlezun, COO, will provide a detailed presentation of the clinical results obtained with AEF0217 in the treatment of cognitive disorders of Down syndrome and answer your questions.
NewCap a conçu une plateforme d’événements sur mesure pour créer, enrichir et pérenniser la relation entre les sociétés cotées et leurs actionnaires.